Research Article

Analysis of Th17 and Tc17 Frequencies and Antiviral Defenses in Gut-Associated Lymphoid Tissue of Chronic HIV-1 Positive Patients

Table 1

Th17 and Th1 frequencies in peripheral blood and gut-associated lymphoid tissue (GALT) samples collected from HIV-1-infected patients () who achieved virological suppression in response to ART therapy.

Frequencies GALTPeripheral blood values

Th17 cells (median/range)1.06/0.21–3.660.26/0.00–0.67
Th1 cells (median/range)5.71/0.23–25.190.16/0.01–28.72
CD4+ DP T cells (median/range) 0.17/0.0–2.280.005/0.0–0.12
Naïve Th17 cells (median/range)1.19/0.0–8.730.09/0.0–0.36
Naïve Th1 cells (median/range)1.01/0.23–11.560.04/0.0–13.0
Naïve CD4+ DP T cells (median/range)0.0/0.0–0.490.0/0.0–0.05
Central memory Th17 cells (median/range)0.935/0.0–3.870.24/0.00–1.19
Central memory Th1 cells (median/range)7.65/0.19–33.140.22/0.0–36.21
Central memory CD4+ DP T cells (median/range)0.15/0.0–3.150.01/0.0–0.14
Effector memory Th17 cells (median/range)0.48/0.0–4.050.21/0.00–1.61
Effector memory Th1 cells (median/range)3.28/0.00–19.530.33/0.0–47.04
Effector memory CD4+ DP T cells (median/range)0.16/0.0–2.030.0/0.0–0.34

Wilcoxon test for paired samples was used to compare Th17 and Th1 frequencies in peripheral blood and GALT. Significant values are highlighted in bold.